Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 916521, 10 pages
http://dx.doi.org/10.1155/2014/916521
Research Article

Differential Macrophage Response to Slow- and Fast-Growing Pathogenic Mycobacteria

1Departamento de Microbiologia, Escuela Nacional de Ciencias Biologicas (ENCB), Instituto Politecnico Nacional (IPN), 11340 México City, DF, Mexico
2Departamento de Inmunobioquímica, Torre de Investigación, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes (INPer), Montes Urales 800, Colonia Lomas de Virreyes, 11000 México City, DF, Mexico
3Departamento de Inmunologia, Escuela Nacional de Ciencias Biologicas, Instituto Politecnico Nacional (IPN), 11340 México City, DF, Mexico
4Departamento of Biomedicina Molecular, Centro de Investigacion y de Estudios Avanzados (CINVESTAV), IPN, 07360 México City, DF, Mexico

Received 5 February 2014; Revised 10 April 2014; Accepted 30 April 2014; Published 18 May 2014

Academic Editor: Angel Cataldi

Copyright © 2014 A. Cecilia Helguera-Repetto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “Global tuberculosis report,” 2013, http://www.who.int/tb/publications/global_report/en/.
  2. A. Baena and S. A. Porcelli, “Evasion and subversion of antigen presentation by Mycobacterium tuberculosis,” Tissue Antigens, vol. 74, no. 3, pp. 189–204, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. D. E. Griffith, T. Aksamit, B. A. Brown-Elliott et al., “An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases,” The American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 4, pp. 367–416, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. J. R. Yu, S. T. Heo, K. H. Lee et al., “Skin and soft tissue infections due to rapidly growing mycobacteria: case series and literature review,” Infection and Chemotherapy, vol. 45, no. 1, pp. 85–93, 2013. View at Google Scholar
  5. W.-J. Koh, Y. H. Kim, O. J. Kwon et al., “Surgical treatment of pulmonary diseases due to nontuberculous mycobacteria,” Journal of Korean Medical Science, vol. 23, no. 3, pp. 397–401, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Bux-Gewehr, H. P. Hagen, S. Rusch-Gerdes, and G. E. Feurle, “Fatal pulmonary infection with Mycobacterium celatum in an apparently immunocompetent patient,” Journal of Clinical Microbiology, vol. 36, no. 2, pp. 587–588, 1998. View at Google Scholar · View at Scopus
  7. J. H. T. Tjhie, A. F. Van Belle, M. Dessens-Kroon, and D. Van Soolingen, “Misidentification and diagnostic delay caused by a false-positive amplified Mycobacterium tuberculosis direct test in an immunocompetent patient with a Mycobacterium celatum infection,” Journal of Clinical Microbiology, vol. 39, no. 6, pp. 2311–2312, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. T. J. Bull, D. C. Shanson, L. C. Archard, M. D. Yates, M. E. Hamid, and D. E. Minnikin, “A new group (type 3) of Mycobacterium celatum isolated from AIDS patients in the London area,” International Journal of Systematic Bacteriology, vol. 45, no. 4, pp. 861–862, 1995. View at Google Scholar · View at Scopus
  9. E. Tortoli, C. Piersimoni, D. Bacosi et al., “Isolation of the newly described species Mycobacterium celatum from AIDS patients,” Journal of Clinical Microbiology, vol. 33, no. 1, pp. 137–140, 1995. View at Google Scholar · View at Scopus
  10. Y. Gholizadeh, A. Varnerot, C. Maslo et al., “Mycobacterium celatum infection in two HIV-infected patients treated prophylactically with rifabutin,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 17, no. 4, pp. 278–281, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Piersimoni, E. Tortoli, F. de Lalla et al., “Isolation of Mycobacterium celatum from patients infected with human immunodeficiency virus,” Clinical Infectious Diseases, vol. 24, no. 2, pp. 144–147, 1997. View at Google Scholar
  12. C. Piersimoni, P. G. Zitti, D. Nista, and S. Bornigia, “Mycobacterium celatum pulmonary infection in the immunocompetent: case report and review,” Emerging Infectious Diseases, vol. 9, no. 3, pp. 399–402, 2003. View at Google Scholar · View at Scopus
  13. S. H. E. Kaufmann, “How can immunology contribute to the control of tuberculosis?” Nature Reviews Immunology, vol. 1, no. 1, pp. 20–30, 2001. View at Google Scholar · View at Scopus
  14. J. M. Tufariello, J. Chan, and J. L. Flynn, “Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection,” The Lancet Infectious Diseases, vol. 3, no. 9, pp. 578–590, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Iona, M. Pardini, M. C. Gagliardi et al., “Infection of human THP-1 cells with dormant Mycobacterium tuberculosis,” Microbes and Infection, vol. 14, no. 11, pp. 959–967, 2012. View at Google Scholar
  16. S. Sturgill-Koszycki, P. H. Schlesinger, P. Chakraborty et al., “Lack of acidification in Mycobacterium phagosomes produced by exclusion vesicular proton-ATPase,” Science, vol. 263, no. 5147, pp. 678–681, 1994. View at Google Scholar · View at Scopus
  17. L. Sanjurjo, N. Amezaga, C. Vilaplana et al., “The scavenger protein apoptosis inhibitor of macrophages (AIM) potentiates the antimicrobial response against Mycobacterium tuberculosis by enhancing autophagy,” PLoS ONE, vol. 8, no. 11, Article ID e79670, 2013. View at Google Scholar
  18. J. Pieters, “Mycobacterium tuberculosis and the Macrophage: maintaining a balance,” Cell Host and Microbe, vol. 3, no. 6, pp. 399–407, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. T. R. Marques da Silva, J. R. De Freitas, Q. Chagas Silva et al., “Virulent Mycobacterium fortuitum restricts NO production by a gamma interferon-activated J774 cell line and phagosome-lysosome fusion,” Infection and Immunity, vol. 70, no. 10, pp. 5628–5634, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Dye, S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione, “Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country,” Journal of the American Medical Association, vol. 282, no. 7, pp. 677–686, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. G. R. Stewart, B. D. Robertson, and D. B. Young, “Tuberculosis: a problem with persistence,” Nature Reviews: Microbiology, vol. 1, no. 2, pp. 97–105, 2003. View at Google Scholar · View at Scopus
  22. O. M. Rivero-Lezcano, C. González-Cortés, D. Reyes-Ruvalcaba, and C. Diez-Tascón, “CCL20 is overexpressed in Mycobacterium tuberculosis-infected monocytes and inhibits the production of reactive oxygen species (ROS),” Clinical and Experimental Immunology, vol. 162, no. 2, pp. 289–297, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. O. H. Vandal, L. M. Pierini, D. Schnappinger, C. F. Nathan, and S. Ehrt, “A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis,” Nature Medicine, vol. 14, no. 8, pp. 849–854, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Singh, D. K. Crossman, D. Mai et al., “Mycobacterium tuberculosis WhiB3 Maintains redox homeostasis by regulating virulence lipid anabolism to modulate macrophage response,” PLoS Pathogens, vol. 5, no. 8, Article ID e1000545, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. D. M. Bouley, N. Ghori, K. L. Mercer, S. Falkow, and L. Ramakrishnan, “Dynamic nature of host-pathogen interactions in Mycobacterium marinum granulomas,” Infection and Immunity, vol. 69, no. 12, pp. 7820–7831, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. M. C. Menendez, M. J. Garcia, M. C. Navarro et al., “Characterization of an rRNA operon (rrnB) of Mycobacterium fortuitum and other mycobacterial species: implications for the classification of mycobacteria,” Journal of Bacteriology, vol. 184, no. 4, pp. 1078–1088, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. S. A. Theus, M. D. Cave, and K. D. Eisenach, “Activated THP-1 cells: an attractive model for the assessment of intracellular growth rates of Mycobacterium tuberculosis isolates,” Infection and Immunity, vol. 72, no. 2, pp. 1169–1173, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Chacón-Salinas, J. Serafín-López, R. Ramos-Payán et al., “Differential pattern of cytokine expression by macrophages infected in vitro with different Mycobacterium tuberculosis genotypes,” Clinical and Experimental Immunology, vol. 140, no. 3, pp. 443–449, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Simeone, A. Bobard, J. Lippmann et al., “Phagosomal rupture by Mycobacterium tuberculosis results in toxicity and host cell death,” PLoS Pathogens, vol. 8, no. 2, Article ID e1002507, 2012. View at Google Scholar
  30. Y. Zhang, M. Doerfler, T. C. Lee, B. Guillemin, and W. N. Rom, “Mechanisms of stimulation of interleukin-1β and tumor necrosis factor-α by Mycobacterium tuberculosis components,” Journal of Clinical Investigation, vol. 91, no. 5, pp. 2076–2083, 1993. View at Google Scholar · View at Scopus
  31. Y. Zhang, M. Broser, H. Cohen et al., “Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components,” Journal of Clinical Investigation, vol. 95, no. 2, pp. 586–592, 1995. View at Google Scholar · View at Scopus
  32. F. C. Bange, A. M. Brown, and W. R. Jacobs Jr., “Leucine auxotrophy restricts growth of Mycobacterium bovis BCG in macrophages,” Infection and Immunity, vol. 64, no. 5, pp. 1794–1799, 1996. View at Google Scholar
  33. A. K. Arriaga, E. H. Orozco, L. D. Aguilar, G. A. W. Rook, and R. Hernández Pando, “Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis,” Clinical and Experimental Immunology, vol. 128, no. 2, pp. 229–237, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. O. V. Vieira and L. Jordao, “Tuberculosis: new aspects of an old disease,” International Journal of Cell Biology, vol. 2011, Article ID 403623, 13 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Gatfield and J. Pieters, “Essential role for cholesterol in entry of mycobacteria into macrophages,” Science, vol. 288, no. 5471, pp. 1647–1650, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. D. N. Dao, L. Kremer, Y. Guérardel et al., “Mycobacterium tuberculosis lipomannan induces apoptosis and interleukin-12 production in macrophages,” Infection and Immunity, vol. 72, no. 4, pp. 2067–2074, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. J. B. Torrelles and L. S. Schlesinger, “Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host,” Tuberculosis, vol. 90, no. 2, pp. 84–93, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Guérardel, E. Maes, E. Elass et al., “Structural study of lipomannan and lipoarabinomannan from Mycobacterium chelonae: presence of unusual components with α1,3-mannopyranose side chains,” Journal of Biological Chemistry, vol. 277, no. 34, pp. 30635–30648, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Y. Armitige, C. Jagannath, A. R. Wanger, and S. J. Norris, “Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages,” Infection and Immunity, vol. 68, no. 2, pp. 767–778, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. D. Kumar and K. V. S. Rao, “Regulation between survival, persistence, and elimination of intracellular mycobacteria: a nested equilibrium of delicate balances,” Microbes and Infection, vol. 13, no. 2, pp. 121–133, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. D. G. Russell, “Phagosomes, fatty acids and tuberculosis,” Nature Cell Biology, vol. 5, no. 9, pp. 776–778, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Koul, T. Herget, B. Klebl, and A. Ullrich, “Interplay between mycobacteria and host signalling pathways,” Nature Reviews Microbiology, vol. 2, no. 3, pp. 189–202, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Gengenbacher and S. H. E. Kaufmann, “Mycobacterium tuberculosis: success through dormancy,” FEMS Microbiology Reviews, vol. 36, no. 3, pp. 514–532, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. I. Vergne, J. Chua, S. B. Singh, and V. Deretic, “Cell biology of Mycobacterium tuberculosis phagosome,” Annual Review of Cell and Developmental Biology, vol. 20, pp. 367–394, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. R. E. Oberley-Deegan, B. W. Rebits, M. R. Weaver et al., “An oxidative environment promotes growth of Mycobacterium abscessus,” Free Radical Biology and Medicine, vol. 49, no. 11, pp. 1666–1673, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. N. Okahashi, T. Okinaga, A. Sakurai et al., “Streptococcus sanguinis induces foam cell formation and cell death of macrophages in association with production of reactive oxygen species,” FEMS Microbiology Letters, vol. 323, no. 2, pp. 164–170, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. W. H. Kim, S. Y. Goo, K.-H. Lee, and S.-J. Park, “Vibrio vulnificus-induced cell death of human mononuclear cells requires ROS-dependent activation of p38 and ERK 1/2 MAPKs,” Immunological Investigations, vol. 38, no. 1, pp. 31–48, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. N. A. Aulik, K. M. Hellenbrand, and C. J. Czuprynski, “Mannheimia haemolytica and its leukotoxin cause macrophage extracellular trap formation by bovine macrophages,” Infection and Immunity, vol. 80, no. 5, pp. 1923–1933, 2012. View at Google Scholar
  49. A. Bohsali, H. Abdalla, K. Velmurugan, and V. Briken, “The non-pathogenic mycobacteria M. smegmatis and M. fortuitum induce rapid host cell apoptosis via a caspase-3 and TNF dependent pathway,” BMC Microbiology, vol. 10, article 237, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. L. M. Delbridge and M. X. O'Riordan, “Innate recognition of intracellular bacteria,” Current Opinion in Immunology, vol. 19, no. 1, pp. 10–16, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Medzhitov, “Inflammation 2010: new adventures of an old flame,” Cell, vol. 140, no. 6, pp. 771–776, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. C.-C. Chen, S.-H. Tsai, C.-C. Lu et al., “Activation of an NLRP3 inflammasome restricts Mycobacterium kansasii infection,” PLoS ONE, vol. 7, no. 4, Article ID e36292, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. F. Abebe, T. Mustafa, A. H. Nerland, and G. A. Bjune, “Cytokine profile during latent and slowly progressive primary tuberculosis: a possible role for interleukin-15 in mediating clinical disease,” Clinical and Experimental Immunology, vol. 143, no. 1, pp. 180–192, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. P. Salgame, “Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection,” Current Opinion in Immunology, vol. 17, no. 4, pp. 374–380, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. J. L. Flynn and J. Chan, “Immunology of tuberculosis,” Annual Review of Immunology, vol. 19, pp. 93–129, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. K. D. Mayer-Barber, D. L. Barber, K. Shenderov et al., “Cutting edge: caspase-1 independent IL-1β production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo,” The Journal of Immunology, vol. 184, no. 7, pp. 3326–3330, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. K. D. Mayer-Barber, B. B. Andrade, D. L. Barber et al., “Innate and adaptive interferons suppress IL-1α and IL-1β production by distinct pulmonary Myeloid subsets during Mycobacterium tuberculosis infection,” Immunity, vol. 35, no. 6, pp. 1023–1034, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. E. McElvania Tekippe, I. C. Allen, P. D. Hulseberg et al., “Granuloma formation and host defense in chronic Mycobacterium tuberculosis infection requires PYCARD/ASC but not NLRP3 or caspase-1,” PLoS ONE, vol. 5, no. 8, Article ID e12320, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. V. Briken, S. E. Ahlbrand, and S. Shah, “Mycobacterium tuberculosis and the host cell inflammasome: a complex relationship,” Frontiers in Cellular and Infection Microbiology, vol. 3, article 62, 2013. View at Google Scholar
  60. E. Volpe, G. Cappelli, M. Grassi et al., “Gene expression profiling of human macrophages at late time of infection with Mycobacterium tuberculosis,” Immunology, vol. 118, no. 4, pp. 449–460, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. B. Wu, C. Huang, M. Kato-Maeda et al., “Messenger RNA expression of IL-8, FOXP3, and IL-12β differentiates latent tuberculosis infection from disease,” The Journal of Immunology, vol. 178, no. 6, pp. 3688–3694, 2007. View at Google Scholar · View at Scopus
  62. H. M. Lee, J. M. Yuk, K. H. Kim et al., “Mycobacterium abscessus activates the NLRP3 inflammasome via Dectin-1-Syk and p62/SQSTM1,” Immunology and Cell Biology, vol. 90, no. 6, pp. 601–610, 2012. View at Google Scholar
  63. E. Ferrero, P. Biswas, K. Vettoretto et al., “Macrophages exposed to Mycobacterium tuberculosis release chemokines able to recruit selected leucocyte subpopulations: focus on γδ cells,” Immunology, vol. 108, no. 3, pp. 365–374, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. P. H. Nibbering, O. Pos, A. Stevenhagen, and R. Van Furth, “Interleukin-8 enhances nonoxidative intracellular killing of Mycobacterium fortuitum by human granulocytes,” Infection and Immunity, vol. 61, no. 8, pp. 3111–3116, 1993. View at Google Scholar · View at Scopus
  65. J. A. Mcgarvey, D. Wagner, and L. E. Bermudez, “Differential gene expression in mononuclear phagocytes infected with pathogenic and non-pathogenic mycobacteria,” Clinical and Experimental Immunology, vol. 136, no. 3, pp. 490–500, 2004. View at Publisher · View at Google Scholar · View at Scopus